Re: Not good for the potential of apabetalone as a Covid-19 therapy
posted on
Dec 03, 2021 12:20PM
Thanks Bear!
You are so helpful and it is much appreciated.
Sorry, just one more thing. I take it your point is that even this statement,
"We observed a marked improvement in mortality, whereby all INCB054329-treated mice survived after 24 h of the LPS-challenge, compared with only 25% in the control group",
still did not really reflect improved survival, because it was only 24 hour survival and all the affected mice died or were euthanized anyway?
Is that correct?